4//SEC Filing
Lorenz Kevin 4
Accession 0001104659-24-000913
CIK 0001429260other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:54 PM ET
Size
6.0 KB
Accession
0001104659-24-000913
Insider Transaction Report
Form 4
Lorenz Kevin
Director
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2024-01-01+3,333→ 24,304 total
Holdings
- 666(indirect: By Spouse)
COMMON STOCK, PAR VALUE $0.001
Footnotes (2)
- [F1]Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
- [F2]One-third of the shares will vest on each of January 1, 2025, 2026, and 2027, subject to continued service.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001772558
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:54 PM ET
- Size
- 6.0 KB